VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 443-449

  Hooper, C E ^a   Elvers, K T ^a   Welsh, G I ^a   Millar, A B ^b   Maskell, N A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Exudate; FLT1; Non small cell lung cancer; Prognosis; Talc; Validation

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURAL EFFUSION; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84863777638     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.03.006     Document Type: Article

References (26)

1. Grove C.S., Lee Y.C.G. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Respir Med 2002, 8(4):294-301.
2. Sack U., Hoffmann M., Zhao X.J., Chan K.S., Hui D.S., Gosse H., et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005, 25:600-604.
3. Thickett D.R., Armstrong L., Millar A.B. Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 1999, 54:707-710.
4. Ferrara N., Gerber H.-P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
5. Harper S.J., Bates D.O. VEGF-A splicing: the key to anti-angiogenic therapeutics?. Nat Rev Cancer 2008, 8:880-887.
6. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
7. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 2001, 33:409-420.
8. Gerber H.P., Condorelli F., Park J., Ferrara N. Differential transcription regulation of the two vascular endothelial growth factor receptor genes. J Biol Chem 1997, 271:23659-23667.
9. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marmé D. Migration of human monocytes in response to vascular endothelilal growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87:3336-3343.
10. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 1993, 90:10705-10709.
11. Tomimoto H., Yano S., Muguruma H., Kakiuchi S., Sone S. levels of soluble vascular endothelial growth factor receptor 1 are elevated in exudative pleural effusions. J Med Invest 2007, 54:146-153.
12. Dressler C.M., Olak J., Herndon J.E., Richards I.I., Scalzetti W.G., Fleishman E., et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005, 127:909-915.
13. Poon T.R., Fan S., Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001, 19(4):1207-1225.
14. Demirag F., Unsal E., Yilmaz A., Caglar A. Prognostic significance of vascular endothelial growth factor tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Chest 2005, 128:3382-3387.
15. Guo Y.B., Kalomenidis I., Hawthorne M., Parman K.S., Lane K.B., Light R.W. Pleurodesis is inhibited by anti-vascular endothelial growth factor antibody. Chest 2005, 128:1790-1797.
16. Goldman C.K., Kendall R.L., Cabrera G., Soroceanu L., Heike Y., Gillespie G.Y., et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A 1998, 95:8795-8800.
17. Roeckl W., Hecht D., Sztajer H., Waltenberger J., Yayon A., Weich H.A. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 1998, 241:161-170.
18. Kong H.L., Hecht D., Song W., Kovesdi I., Hackett N.R., Yayon A., et al. Regional suppression of tumour growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum Gene Ther 1998, 1998(9):823-833.
19. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial cell growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
20. Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., et al. Mutant ras oncogenes upregulate VEGFIVPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995, 55:4575-4580.
21. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol chem 1994, 269:6271-6274.
22. Roberts M.E., Neville E., Berrisford R.G., Antunes G., Ali N.J. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010, 65(2):ii32-ii40.
23. Marchi E., Vargas F.S., Acencio M.M., Antonangelo L., Genofre E.H., Teixeira L.R. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur Respir J 2006, 28(5):929-932.
24. Teixeira L.R., Vargas F.S., Acencio M.M., Ribeiro S.C., Sales R.K., Antonangelo L., et al. Blockage of vascular endothelial growth factor (VEGF) reduces experimental pleurodesis. Lung Cancer 2011, Online first.
25. Yano S., Shinohara H., Herbst R.S., Kuniyasu H., Bucana C.D., Ellis L.M., et al. Production of experimental malignant effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am J Pathol 2000, 157:1893-1903.
26. Kotyza J., Havel D., Vrzalova J., Kulda V., Pesek M. Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusions. Int J Biol Markers 2010, 25(1):12-20.